Harbeck N - Search Results

1

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial.

Lu YS, Im SA, Colleoni M, Franke F, Bardia A, Cardoso F, Harbeck N, Hurvitz S, Chow L, Sohn J, Lee KS, Campos-Gomez S, Villanueva Vazquez R, Jung KH, Babu KG, Wheatley-Price P, De Laurentiis M, Im YH, Kuemmel S, El-Saghir N, O'Regan R, Gasch C, Solovieff N, Wang C, Wang Y, Chakravartty A, Ji Y, Tripathy D. Lu YS, et al. Among authors: harbeck n. Clin Cancer Res. 2022 Mar 1;28(5):851-859. doi: 10.1158/1078-0432.CCR-21-3032. Clin Cancer Res. 2022. PMID: 34965945 Free PMC article. Clinical Trial.

2

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.

Harbeck N, Untch M, Pache L, Eiermann W. Harbeck N, et al. Br J Cancer. 1994 Mar;69(3):566-71. doi: 10.1038/bjc.1994.103. Br J Cancer. 1994. PMID: 7510120 Free PMC article.

3

Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination.

Harbeck N, Kates RE, Schmitt M. Harbeck N, et al. J Clin Oncol. 2002 Feb 15;20(4):1000-7. doi: 10.1200/JCO.2002.20.4.1000. J Clin Oncol. 2002. PMID: 11844823

4

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

Harbeck N, Kates RE, Look MP, Meijer-Van Gelder ME, Klijn JG, Krüger A, Kiechle M, Jänicke F, Schmitt M, Foekens JA. Harbeck N, et al. Cancer Res. 2002 Aug 15;62(16):4617-22. Cancer Res. 2002. PMID: 12183417

5

Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts.

Harbeck N, Schmitt M, Kates RE, Kiechle M, Zemzoum I, Jänicke F, Thomssen C. Harbeck N, et al. Clin Breast Cancer. 2002 Aug;3(3):196-200. doi: 10.3816/CBC.2002.n.023. Clin Breast Cancer. 2002. PMID: 12196277 Review.

6

Antibody therapy for breast cancer.

Willems A, Gauger K, Henrichs C, Harbeck N. Willems A, et al. Among authors: harbeck n. Anticancer Res. 2005 May-Jun;25(3A):1483-9. Anticancer Res. 2005. PMID: 16033049 Free article. Review.

7

FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.

Thussbas C, Nahrig J, Streit S, Bange J, Kriner M, Kates R, Ulm K, Kiechle M, Hoefler H, Ullrich A, Harbeck N. Thussbas C, et al. Among authors: harbeck n. J Clin Oncol. 2006 Aug 10;24(23):3747-55. doi: 10.1200/JCO.2005.04.8587. Epub 2006 Jul 5. J Clin Oncol. 2006. PMID: 16822847

8

Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.

Dorn J, Schmitt M, Kates R, Schmalfeldt B, Kiechle M, Scorilas A, Diamandis EP, Harbeck N. Dorn J, et al. Among authors: harbeck n. Clin Cancer Res. 2007 Mar 15;13(6):1742-8. doi: 10.1158/1078-0432.CCR-06-2482. Clin Cancer Res. 2007. PMID: 17363527

9

A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer.

Llombart-Cussac A, Martin M, Harbeck N, Anghel RM, Eniu AE, Verrill MW, Neven P, De Grève J, Melemed AS, Clark R, Simms L, Kaiser CJ, Ma D. Llombart-Cussac A, et al. Among authors: harbeck n. Clin Cancer Res. 2007 Jun 15;13(12):3652-9. doi: 10.1158/1078-0432.CCR-06-2377. Clin Cancer Res. 2007. PMID: 17575230 Clinical Trial.

10

Treatment strategies that effectively reduce early recurrence risk in postmenopausal women with endocrine-sensitive breast cancer: AIs upfront vs. switching.

Paepke S, Jacobs VR, Ohlinger R, Warm M, Kümmel S, Thomas A, Harbeck N, Kiechle-Bahat M. Paepke S, et al. Among authors: harbeck n. J Cancer Res Clin Oncol. 2007 Dec;133(12):905-16. doi: 10.1007/s00432-007-0297-7. Epub 2007 Sep 6. J Cancer Res Clin Oncol. 2007. PMID: 17805570 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

690 results

Search Page